Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 850, Issue 1-2, 2007, Pages 538-543

  Rodriguez Rosas, Maria Esther ^a   Lofwall, Michelle R ^b   Strain, Eric C ^c   Siluk, Danuta ^a,d   Wainer, Irving W ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

(R) EDDP; (R) methadone; (S) EDDP; (S) methadone; AGP chiral stationary phase; Buprenorphine; Chiral chromatography; LC MS; Norbuprenorphine

Indexed keywords

AGP CHIRAL STATIONARY PHASE; BUPRENORPHINE; CHIRAL CHROMATOGRAPHY; NORBUPRENORPHINE;

BIOASSAY; ENANTIOMERS; KETONES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PLASMA (HUMAN);

AMINES;

1,5 DIMETHYL 3,3 DIPHENYL PYRROLIDINE; ACETONITRILE; AMMONIUM ACETATE; BUPRENORPHINE; METHADONE; NORBUPRENORPHINE; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; ENANTIOMER; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PH; PRIORITY JOURNAL;

BUPRENORPHINE; CALIBRATION; HUMANS; MASS SPECTROMETRY; METHADONE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34247260510     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.11.025     Document Type: Article

References (33)

1. Walsh S.L., Preston K.L., Bigelow G.E., and Stitzer M.L. J. Pharmacol. Exp. Ther. 274 (1995) 361
2. Kobayashi K., Yamamoto T., Chiba K., Tani M., Shimada N., Ishizaki T., and Kuroiwa Y. Drug Metab. Dispos. 26 (1998) 818
3. Cirimele V., Kintz P., Lohner S., and Ludes B. J. Anal. Toxicol. 27 March (2) (2003) 103
4. De Giovanni N., Fucci N., Scarlata S., and Donzelli G. Clin. Chem. Lab. Med. 43 12 (2005) 1377
5. Hand C.W., Baldwin D., Moore R.A., Allen M.C., and McQuay H.J. Ann. Clin. Biochem. 23 (1986) 47
6. Bottcher M., and Beck O. J. Anal. Toxicol. 29 November-December (8) (2005) 769
7. Cone E.J., Gorodetzky C.W., Yousefnejad D., and Darwin W.D. J. Chromatogr. 337 (1985) 291
8. Everhart E.T., Cheung P., Shwonek P., Zabel K., Tisdale E.C., Jacob P., Mendelson J., and Jones R.T. Clin. Chem. 43 (1997) 2292
9. Debrabandere L., Van Boven M., and Daenens P. J. Forensic Sci. 37 (1991) 82
10. Schleyer E., Lohmann R., Rolf C., Gralow A., Kaufmann C.C., Unterhalt M., and Hiddemann W. J. Chromatogr. 614 (1993) 275
11. Salem A., Pierce T.L., and Hope W. J. Pharmacol. Toxicol. Meth. 37 (1997) 75
12. Liu S.Y., Liu K.S., Kuei C.H., Tzeng J.I., Ho S.T., and Wang J.J. J. Chromatogr. B 818 April (2) (2005) 233
13. Ohtani M., Shibuya F., Kotaki H., Uchino K., Saitoh Y., and Nakagawa F. J. Chromatogr. 487 (1989) 469
14. George S., George C., and Chauhan M. Forensic Sci. Int. 143 (2004) 121
15. Elsohly M.A., Gul W., Feng S., and Murphy T.P. J. Anal. Toxicol. 29 September (2005) 570
16. Pirnay S., Bouchonnet S., Herve F., Libong D., Milan N., D'Athis P., Baud F., and Ricordel I. J. Chromatogr. B 807 August (2) (2004) 335
17. Kintz S. Clin. Biochem. 35 October (7) (2002) 513
18. Bogusz M.J. J. Chromatogr. B 748 October (1) (2000) 3
19. Hoja H., Marquet P., Verneuil B., Lotfi H., Dupuy J.L., and Lachatre G. J. Anal. Toxicol. 21 March-April (2) (1997) 160
20. Tracqui A., Kintz P., and Mangin P. J. Forensic Sci. 42 January (1) (1997) 111
21. Moody D.E., Slawson M.H., Strain E.C., Laycock J.D., Spanbauer A.C., and Foltz R.L. Anal. Biochem. 306 (2002) 31
22. Polettini A., and Huestis M.A. J. Chromatogr. B 754 (2001) 447
23. Murphy C.M., and Huestis M.A. J. Mass Spectrom. 40 January (1) (2005) 70
24. Ceccato A., Klinkenberg R., Hubert P., and Streel B. J. Pharm. Biomed. Anal. 32 August (4-5) (2003) 619
25. Favretto D., Frison G., Vogliardi S., and Ferrara S.D. Rapid Commun. Mass Spectrom. 20 8 (2006) 1257
26. Schottenfeld R.S., Chawarski M.C., Pakes J.R., Pantalon M.V., Caroll K.M., and Kosten T.R. Am. J. Psychiatry 162 February (2) (2005) 340
27. Greenwald M.K., Johanson C.E., Moody D.E., Woods J.H., Kilbourn M.R., Koeppe R.A., Schuster C.R., and Zubieta J.K. Neuropsychopharmacology 28 November (11) (2003) 2000
28. Ortner R., Jagsch R., Schindler S.D., Primorac A., and Fischer G. Eur. Addict. Res. 10 (2004) 105
29. Gonzalez G., Oliveto A., and Kosten T.R. Curr. Opin. Pharmacother. 5 (2004) 713
30. Rodriguez-Rosas M.E., Preston K.L., Epstein D.H., Moolchan E.T., and Wainer I.W. J. Chromatogr. B 796 (2003) 355
31. Rodriguez-Rosas M.E., Medrano J.G., Epstein D.H., Moolchan E.T., Preston K.L., and Wainer I.W. J. Chromatogr. A 1073 (2005) 237
32. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 75 (2003) 3019
33. Guidance for Industry. Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, May 2001.